| Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction NME Ayman Geddawy , Yasmine F. Ibrahim journal of transnational internal Medicine 5 (1), 8-17, 2017 | 204* | 2017 |
| Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity MA Ibrahim, OM Ashour, YF Ibrahim, HI El-Bitar, W Gomaa, ... Pharmacological research 60 (5), 373-381, 2009 | 160 | 2009 |
| Nonalcoholic fatty liver disease: current and potential therapies MA Ibrahim, M Kelleni, A Geddawy Life sciences 92 (2), 114-118, 2013 | 117 | 2013 |
| Potential protective effect of etanercept and aminoguanidine in methotrexate-induced hepatotoxicity and nephrotoxicity in rats HM Hafez, MA Ibrahim, SA Ibrahim, EF Amin, W Goma, AM Abdelrahman European journal of pharmacology 768, 1-12, 2015 | 91 | 2015 |
| Protective effect of peroxisome proliferator activator receptor (PPAR)-α and-γ ligands against methotrexate-induced nephrotoxicity MA Ibrahim, AAK El-Sheikh, HM Khalaf, AM Abdelrahman Immunopharmacology and Immunotoxicology 36 (2), 130-137, 2014 | 62 | 2014 |
| Effect of sofosbuvir plus daclatasvir in hepatitis C virus genotype-4 patients: promising effect on liver fibrosis AM Abdel-Aziz, MA Ibrahim, AA El-Sheikh, MY Kamel, NM Zenhom, ... Journal of clinical and experimental hepatology 8 (1), 15-22, 2018 | 44 | 2018 |
| Nephroprotective effect of cilostazol and verapamil against thioacetamide-induced toxicity in rats may involve Nrf2/HO-1/NQO-1 signaling pathway HM Hafez, MA Ibrahim, MZ Zedan, M Hassan, H Hassanein Toxicology mechanisms and methods 29 (2), 146-152, 2019 | 43 | 2019 |
| Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury MA Ibrahim, SA Abdel-Gaber, EF Amin, SA Ibrahim, RK Mohammed, ... European journal of pharmacology 741, 64-73, 2014 | 36 | 2014 |
| Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats MA Ibrahim, EF Amin, SA Ibrahim, WY Abdelzaher, AM Abdelrahman European journal of pharmacology 724, 204-210, 2014 | 36 | 2014 |
| Diacerein protects rats with liver ischemia/reperfusion damage: down-regulation of TLR4/NFκ-B signaling pathway MA Ibrahim, WY Abdelzaher, YF Ibrahim, AF Ahmed, NN Welson, ... Biomedicine & Pharmacotherapy 134, 111063, 2021 | 31 | 2021 |
| Effect of selective versus non-selective cyclooxygenase inhibitors on ischemia–reperfusion-induced hepatic injury in rats SA Abdel-Gaber, MA Ibrahim, EF Amin, SA Ibrahim, RK Mohammed, ... Life Sciences 134, 42-48, 2015 | 31 | 2015 |
| Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease AAM Ibrahim M, Farghaly E, Gomaa W, Kelleni M European journal of pharmacology 659 (2-3), 289-295, 2011 | 31 | 2011 |
| Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats AMAA Mohamed A Ibrahim, MASA Haleem, SS A AbdelWahab Hum Exp Toxicol 40 (4), 596-607, 2021 | 30 | 2021 |
| Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes MA Ibrahim, A Geddawy, S Abdel-Wahab European journal of pharmacology 829, 63-69, 2018 | 30 | 2018 |
| Effect of selective and non-selective cyclooxygenase inhibitors on doxorubicin-induced cardiotoxicity and nephrotoxicity in rats MA Ibrahim, MA Morsy, HM Hafez, WM Gomaa, AM Abdelrahman Toxicology Mechanisms and Methods 22 (6), 424-431, 2012 | 18 | 2012 |
| Effect of diabetes on aortic nitric oxide synthesis in spontaneously hypertensive rats; does captopril modulate this effect? MA Ibrahim, T Kanzaki, S Yamagata, N Satoh, S Ueda Life sciences 77 (9), 1003-1014, 2005 | 17 | 2005 |
| Efficacy and safety of combined low doses of either diclofenac or celecoxib with gabapentin versus their single high dose in treatment of neuropathic pain in rats MA Ibrahim, WY Abdelzaher, RR Rofaeil, S Abdelwahab Biomedicine & Pharmacotherapy 100, 267-274, 2018 | 16 | 2018 |
| Molecular mechanisms underlying the protective effect of telmisartan in non-alcoholic fatty liver disease: role of proinflammatory enzymes. SAHA Ibrahim MA, Adel Saad Egypt. J. of Basic and Clinical Pharmacology 1 (1), 1-8, 2011 | 16* | 2011 |
| Nitric oxide levels and sustained virological response to pegylated-interferon alpha2a plus ribavirin in chronic HCV genotype 4 hepatitis: A prospective study. M Ibrahim, W Gomaa, Y Ibrahim, H El Hadad, M Shatat, AA Aleem, ... Journal of Gastrointestinal & Liver Diseases 19 (4), 2010 | 14 | 2010 |
| Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats MA Ibrahim, A Abdel-Aziz, A El-Sheikh, M Kamel, AZ Khalil, ... Clinical and Experimental Hepatology 4 (3), 175-181, 2018 | 13 | 2018 |
